Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 41Gynecologic 11Genitourinary 7Dermatologic 7Tumor-Agnostic 6Sarcoma 6Other hematologic neoplasm 6Thoracic 5Lymphoid 5CNS 4Endocrine 3Other solid neoplasm 2Head & Neck 2Breast 2Plasma cell 1Myeloid 1

Conditions

Breast Neoplasms 2Stomach Neoplasms 1Pancreatic Neoplasms 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × aflibercept × Breast × Clear all
NCT01843725 2018-01-31

MOMENTUM1

Jules Bordet Institute

Phase 1 Completed
37 enrolled
BreastGastrointestinal

Biliary Tract Neoplasms, Breast Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00369655 2014-05-05

VEGF Trap in Treating Patients With Metastatic Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
21 enrolled 22 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡